- Home
- CRL vs AES Comparison
CRL vs AES Comparison
Compare CRL & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRL | AES |
|---|---|---|
| Founded | 1947 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.9B |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CRL | AES |
|---|---|---|
| Price | $160.58 | $14.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 10 |
| Target Price | ★ $198.27 | $15.29 |
| AVG Volume (30 Days) | 790.6K | ★ 11.9M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | $1,857,601,000.00 | ★ $12,233,000,000.00 |
| Revenue This Year | N/A | $5.22 |
| Revenue Next Year | $3.04 | $4.81 |
| P/E Ratio | ★ N/A | $21.61 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $132.58 | $9.58 |
| 52 Week High | $228.88 | $17.65 |
Technical Indicators
Market Signals| Indicator | CRL | AES |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 68.14 |
| Support Level | $147.22 | $14.01 |
| Resistance Level | $166.62 | $15.02 |
| Average True Range (ATR) | 8.97 | 0.10 |
| MACD | -1.18 | 0.04 |
| Stochastic Oscillator | 31.12 | 91.00 |
Price Performance
Historical ComparisonAbout CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.